CompoAtlas

Syléance Minceur 4 en 1

Food supplement declared in France, declaration No 2018-1-464

Syléance Minceur 4 en 1 (Yves Ponroy) is a food supplement declared in France. Status: withdrawal from the market announced for 15 July 2027. Main ingredients: Opuntia ficus-indica 2,000 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Yves Ponroy
Food business operator placing the product on the market
HAVEA COMMERCIAL SERVICES
Status
Withdrawal from the market announced for 15 July 2027
Form
Capsule
Daily dose
6 gélules
Directions for use
à avaler
Intended populations
Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Slimming / Binder, Weight management / Slimming, Slimming / Appetite control

Declaration 153034, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Opuntia ficus-indica (L.) Mill.RaquettePoudre (de plantes séchées ou broyées)2,000 mg

Additives

E553b

Other ingredients

gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Yves Ponroy

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Syléance Minceur 4 en 1 (Yves Ponroy): composition and regulation”, https://compoatlas.com/en/supplements/products/153034-syleance-minceur-4-en-1, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line